Liraglutide Reduces Both Atherosclerosis and Kidney Inflammation in Moderately Uremic LDLr-/- Mice

• Line S. Bisgaard,

  Affiliations Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark, Global Research, Novo Nordisk, Måløv, Denmark

  ⨯
• Markus H. Bosteen,

  Affiliations Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark, Department of Clinical Biochemistry, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark

  ⨯
• Lisbeth N. Fink,

  Affiliation Global Research, Novo Nordisk, Måløv, Denmark

  ⨯
• Charlotte M. Sørensen,

  Affiliation Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark

  ⨯
• Alexander Rosendahl,

  Current address: Shire, Medical Affairs Nordics, Søborg, Denmark

  Affiliation Global Research, Novo Nordisk, Måløv, Denmark

  ⨯
• Christina K. Mogensen,

  Affiliation Global Research, Novo Nordisk, Måløv, Denmark

  ⨯
• Salka E. Rasmussen,

  Affiliation Global Research, Novo Nordisk, Måløv, Denmark

  ⨯
• Bidda Rolin,

  Affiliation Global Research, Novo Nordisk, Måløv, Denmark

  ⨯
• Lars B. Nielsen,

  Affiliations Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark, Department of Clinical Biochemistry, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark

  ⨯
• Tanja X. Pedersen

  * E-mail: tanjax@sund.ku.dk

  Affiliation Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark

  http://orcid.org/0000-0003-2515-3022

  ⨯